Now Available: Multiple Myeloma Luciferase Cell Lines

Imanis Life Sciences

Menu

Latest News

Stay up to date on the latest....

ASCO Update: Oncolytic virotherapy with immune modulators

March 21, 2017

Virotherapy in combination with immune modulators such as checkpoint inhibitors at ASCO-SITC. Presentation by Dr. Stephen Russell, Mayo Clinic.

Continue Reading

Imanis Life Sciences Launches Line of Oncolytic Vaccinia Viruses From Genelux Corporation

February 23, 2017

ROCHESTER, Minn., February 23, 2017 — Imanis Life Sciences announced today the launch of a new product line of oncolytic vaccinia viruses for virotherapy research. These viruses are licensed from Genelux Corporation as part of Genelux’s proprietary, vaccinia virus-based technology platform for research use. “We are excited to enter into a partnership with Genelux to offer […]

Continue Reading

NEW human NIS with enhanced TFB uptake for superior PET imaging of NIS in gene, cells and virus studies

November 16, 2016

Imanis is proud to announce the launch of a new line of NIS specifically tailored for PET imaging using the high sensitive tracer F18-tetrafluoroborate. This new NIS, NISplus, has been generated through mutagenesis and molecular modeling and has enhanced uptake of the PET tracer compared to wild type parental human NIS. It is now available […]

Continue Reading

NEW: Oncolytic recombinant herpes simplex virus 1 (HSV-1)

November 9, 2016

Imanis is pleased to announce the availability of three new recombinant HSV-1 viruses encoding reporter genes for use in in vitro and in vivo studies. These ready to use HSV-1 vectors encode the human sodium iodide symporter (hNIS), firefly luciferase (FLuc) or green fluorescent protein (GFP). These viruses have been thoroughly validated by our team […]

Continue Reading

NEW anti-NIS antibodies from Imanis Life

July 28, 2015

Imanis is proud to present our newly generated anti-NIS antibody. Applications tested include western blotting, immunofluorescence staining, immunohistochemical staining. Works on cryosections and paraffin embedded tissues. Recommended dilution: 1:2000 (the best out there!). BUY NOW!  

Continue Reading

Thank you for visiting us at the vendor show at Mayo Clinic Rochester

July 24, 2015

Imanis staff (Sam Russell and Chris Chen) explaining to scientists why NIS (the sodium iodide symporter) is the preferred reporter gene for in vivo imaging in small and large animals. (1) Non immunogenic, (2) High Resolution 3D imaging data, (3) Easy to use radiotracers (radioiodine or Tc-99m).

Continue Reading

First Midwest Preclinical Imaging Consortium Workshop

April 16, 2015

Imanis Life Sciences will be participating in the first Midwest Preclinical Imaging Consortium Workshop to be held on the campus of Mayo Clinic Rochester, April 19-20, 2015, Leighton Auditorium. This workshop is jointly organized by Mayo Clinic and Northwestern University, to encourage interactions and collaborative research between academic institutes and companies located in the Midwest. […]

Continue Reading

Imanis NIS Reporter Gene Imaging Featured in MI Labs Newsletter

March 13, 2015

You will learn how and why NIS reporter gene imaging is an important part of drug development in virus, gene and cell therapies.   Q&A: 1. Can you explain what NIS reporter genes are and how they can be used in cancer  therapy? 2. So how can NIS reporter genes been used for other non-thyroid oncology […]

Continue Reading

New cell lines introduced ushering amazing potential

November 12, 2014

Please visit Product Lines (Cell Lines) to find out what is available. Custom generation of reporter gene expressing cell lines may better serve your needs. Visit our Assays and Services page to request a quote. Find out for yourself how NIS reporter gene imaging can give you an advantage over optical imaging methods. Highly popular are reporter cell lines […]

Continue Reading

Imanis is honored with an award from the LifeScience Alley New Technology Showcase Winner 2013

MINNEAPOLIS, Sep 26, 2013 (BUSINESS WIRE) — LifeScience Alley announced today that 10 life science and health technology organizations will be exhibiting cutting-edge products as part of the association’s New Technology Showcase at the 2013 LifeScience Alley Conference. Three of the 10 selected organizations will be presenting their technologies during the luncheon plenary session in […]

Continue Reading

Learn More